Menorrhagia from a haematologist's point of view. Part II: management.
The management of menorrhagia has until recently been the domain of the gynaecologist. As haematologists, we are now addressing the issue of optimal management of menorrhagia in our patients with bleeding disorders. Addressing three life periods, the menarche, reproductive years, and postchildbearing years, this review will discuss the use of oral contraceptive agents, antifibrinolytics, non-steroidal anti-inflammatory drugs, intranasal DDAVP and the new levonorgestrel-impregnated IUD. Management of specific bleeding disorders will also be reviewed for von Willebrand disease, haemophilia A and B carriers, women with factor XI deficiency and PAI-1 deficiency.
Siegel
J E
JE
Cardeza Foundation Hemophilia Treatment Center at Thomas Jefferson University, Philadelphia, PA 19107, USA. jamie.siegel@mail.tju.edu
Kouides
P A
PA
D019468:Disease Management; D005260:Female; D006405:Hematology / Q000379:methods; D006801:Humans; D008595:Menorrhagia / Q000188:drug therapy* / Q000209:etiology; D017698:Postmenopause; D017697:Premenopause